Suppr超能文献

代偿期肝硬化患者孤立性1厘米至2厘米肝脏结节的管理:一项决策分析。

Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

作者信息

Bremner Karen E, Bayoumi Ahmed M, Sherman Morris, Krahn Murray D

机构信息

Toronto General Research Institute, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

出版信息

Can J Gastroenterol. 2007 Aug;21(8):491-500. doi: 10.1155/2007/182383.

Abstract

OBJECTIVES

Current guidelines, based on expert opinion, recommend that suspected 1 cm to 2 cm hepatocellular carcinoma (HCC) detected on screening be biopsied and, if positive, treated (eg, resection or transplantation). Alternative strategies are immediate treatment or observation until disease progression occurs.

METHODS

A Markov decision model was developed that compared three management strategies - immediate resection, biopsy and resection if positive, and ultrasound surveillance every three months until disease progression - for a single 1 cm to 2 cm liver nodule suspicious for HCC following ultrasound screening and computed tomography confirmation. The cohort included 55-year-old patients with compensated cirrhosis and no significant comorbidities. The model used in the present study incorporated the probabilities of false-positive and false-negative results, needle-track seeding, HCC recurrence, cirrhosis progression and death. The quality-adjusted life expectancy (LE) and the unadjusted LE were evaluated and the model's strength was assessed with sensitivity analyses.

RESULTS

In the base case analysis, biopsy, resection and surveillance yielded an unadjusted LE of 60.5, 59.7 and 56.6 months, respectively, and a quality-adjusted LE of 46.6, 45.6 and 43.8 months, respectively. In probabilistic sensitivity analyses, biopsy was the preferred strategy 69.5% of the time, resection 30.5% of the time and surveillance never. Resection was the optimal decision if the sensitivity of biopsy was very low (less than 0.45) or if the accuracy of the imaging tests resulted in a high percentage of HCC-positive patients (greater than 76%) in the screened cohort, as with expert interpretation of triphasic computed tomography.

CONCLUSIONS

The present model suggests that biopsy is the preferred management strategy for these patients. When postimaging probability of HCC is high or pathology expertise is lacking, resection is the best alternative. Surveillance is never the optimal strategy.

摘要

目的

基于专家意见的现行指南建议,对筛查发现的直径1厘米至2厘米的疑似肝细胞癌(HCC)进行活检,若活检结果为阳性则进行治疗(如切除或移植)。其他策略包括立即治疗或观察直至疾病进展。

方法

建立了一个马尔可夫决策模型,比较了三种管理策略——立即切除、活检阳性则切除以及每三个月进行超声监测直至疾病进展——针对超声筛查和计算机断层扫描确认后单个直径1厘米至2厘米的肝脏结节疑似HCC的情况。队列包括55岁、代偿期肝硬化且无明显合并症的患者。本研究中使用的模型纳入了假阳性和假阴性结果、针道种植、HCC复发、肝硬化进展和死亡的概率。评估了质量调整预期寿命(LE)和未调整的LE,并通过敏感性分析评估了模型的稳健性。

结果

在基础病例分析中,活检、切除和监测的未调整LE分别为60.5个月、59.7个月和56.6个月,质量调整LE分别为46.6个月、45.6个月和43.8个月。在概率敏感性分析中,活检在69.5%的时间里是首选策略,切除在30.5%的时间里是首选策略,监测从未是首选策略。如果活检的敏感性非常低(低于0.45)或成像检查的准确性导致筛查队列中HCC阳性患者的比例很高(大于76%),如对三相计算机断层扫描的专家解读那样,切除是最佳决策。

结论

本模型表明,活检是这些患者的首选管理策略。当HCC的成像后概率很高或缺乏病理专业知识时,切除是最佳替代方案。监测永远不是最佳策略。

相似文献

本文引用的文献

2
Management of hepatocellular carcinoma.肝细胞癌的管理
Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.
3
Estimation of utilities for chronic hepatitis C from SF-36 scores.根据SF-36评分估算慢性丙型肝炎的效用值。
Am J Gastroenterol. 2005 Mar;100(3):643-51. doi: 10.1111/j.1572-0241.2005.40976.x.
8
Hepatocellular carcinoma: current surgical management.肝细胞癌:当前的外科治疗方法
Gastroenterology. 2004 Nov;127(5 Suppl 1):S248-60. doi: 10.1053/j.gastro.2004.09.039.
9
Computed tomographic imaging of hepatocellular carcinoma.肝细胞癌的计算机断层扫描成像
Gastroenterology. 2004 Nov;127(5 Suppl 1):S133-43. doi: 10.1053/j.gastro.2004.09.027.
10
Pathogenesis and screening for hepatocellular carcinoma.肝细胞癌的发病机制与筛查
Clin Liver Dis. 2004 May;8(2):419-43, viii. doi: 10.1016/j.cld.2004.02.002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验